Search clinical trials for: Prodarsan
Total 1 results
-
DNage B.V.CompletedCockayne SyndromeUnited States
Sponsors and Collaborators
- San MediTech(Huzhou)Co.,Ltd.
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- The Fifth Affiliated Hospital of Zunyi Medical College
- Alberta Children's Hospital, Calgary, Canada
- Diego Hernan Giunta, MD
- Fondren Orthopedic Group L.L.P.
- Elim Pediatric Pharmaceuticals Inc.
- Caritas Freetown
- AMTC & Associates
- Celtaxsys Aus Pty Limited
- Norsk Proteinintolerance, Norway
- Societa Italiana di Endoscopia Digestiva
- Rui-hua Xu, MD, PhD
- ProteoSys AG
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- University Medical Center Goettingen
- Cardresearch
- CRMBM-CEMEREM
- Victor Montori
- Donders Institute for Brain, Cognition and Behavior
- View Full List
Medical Conditions
- Gynecologic Cancer
- Malignant Ascites Due to Epithelial Carcinoma
- Atrial Fibrillation, Postoperative
- Fibromyalgia Syndrome, Primary
- Non-compressible Torso Hemorrhage
- Non-dystrophic Myotonias
- Tularaemia
- Prostate Cancer Recurrent
- Plasmodium Falciparum Malaria (Drug Resistant)
- Stereotactic Radioablation for Ventricular Tachycardia
- Lymphedema of Arm
- Tube Disorders Eustachian
- Orbital Tumor
- Disturbance of Activity and Attention
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Normal Diameter of Optic Nerve
- Spermatogenesis Arrest
- Auditory Hallucination, Verbal
- Postcomatose Unawareness State
- Fever, Sweats, and Hot Flashes
- View Full List
Drug Interventions
- Atezolizumab
- Ruxolitinib
- Methotrexate
- Lamivudine
- Indoximod
- Cetrorelix 78 mg + 78 mg
- PF-00868554
- Insulin
- Enzalutamide, Abiraterone
- Oxycodone, fentanyl
- Polyethylene glycol 3350
- Bortezomib/dexamethasone
- SERETIDE Diskus
- Topotecan
- Flibanserin 100 mg dose every evening
- Epimedium Prenylflavonoids Extract
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Cytarabine ARA-C
- Mupirocin Calcium
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Benin
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Guinea
- Contract Research Organizations in Iran
- Contract Research Organizations in Mexico
- Contract Research Organizations in Poland
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Singapore
- Contract Research Organizations in Sweden
- Contract Research Organizations in Togo
- Contract Research Organizations in Tunisia
- CRO list by country